List of Tables
    Table 1. Global Therapeutic Peptide Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injection
    Table 4. Major Manufacturers of Other
    Table 5. Global Therapeutic Peptide Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 6. Global Therapeutic Peptide Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 7. Global Therapeutic Peptide Sales by Regions (2016-2021) & (K Units)
    Table 8. Global Therapeutic Peptide Sales Market Share by Regions (2016-2021)
    Table 9. Global Therapeutic Peptide Revenue by Regions (2016-2021) & (US$ Million)
    Table 10. Global Therapeutic Peptide Sales Forecast by Region (2022-2027) & (K Units)
    Table 11. Global Therapeutic Peptide Sales Market Share Forecast by Region (2022-2027)
    Table 12. Global Therapeutic Peptide Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 13. Global Therapeutic Peptide Revenue Market Share Forecast by Region (2022-2027)
    Table 14. Global Therapeutic Peptide Sales by Manufacturers (2016-2021) (K Units)
    Table 15. Global Therapeutic Peptide Sales Share by Manufacturers (2016-2021)
    Table 16. Ranking of Global Top Therapeutic Peptide Manufacturers by Revenue (US$ Million) in 2020
    Table 17. Therapeutic Peptide Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 18. Therapeutic Peptide Revenue Share by Manufacturers (2016-2021)
    Table 19. Global Therapeutic Peptide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 20. Global Therapeutic Peptide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Peptide as of 2020)
    Table 21. Key Manufacturers Therapeutic Peptide Price (2016-2021) (US$/Unit)
    Table 22. Therapeutic Peptide Manufacturers Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Therapeutic Peptide Product Type
    Table 24. Date of International Manufacturers Enter into Therapeutic Peptide Market
    Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 26. Global Therapeutic Peptide Sales by Type (2016-2021) (K Units)
    Table 27. Global Therapeutic Peptide Sales Share by Type (2016-2021)
    Table 28. Global Therapeutic Peptide Revenue by Type (2016-2021) (US$ Million)
    Table 29. Global Therapeutic Peptide Revenue Share by Type (2016-2021)
    Table 30. Therapeutic Peptide Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 31. Global Therapeutic Peptide Sales Forecast by Type (2022-2027) & (K Units)
    Table 32. Global Therapeutic Peptide Sales Market Share Forecast by Type (2022-2027)
    Table 33. Global Therapeutic Peptide Revenue Forecast V (2022-2027) & (US$ Million)
    Table 34. Global Therapeutic Peptide Revenue Market Share Forecast by Type (2022-2027)
    Table 35. Global Therapeutic Peptide Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 36. Global Therapeutic Peptide Sales by Application (2016-2021) (K Units)
    Table 37. Global Therapeutic Peptide Sales Share by Application (2016-2021)
    Table 38. Global Therapeutic Peptide Revenue by Application (2016-2021) (US$ Million)
    Table 39. Global Therapeutic Peptide Revenue Share by Application (2016-2021)
    Table 40. Therapeutic Peptide Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 41. Global Therapeutic Peptide Sales Forecast by Application (2022-2027) & (K Units)
    Table 42. Global Therapeutic Peptide Sales Market Share Forecast by Application (2022-2027)
    Table 43. Global Therapeutic Peptide Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 44. Global Therapeutic Peptide Revenue Market Share Forecast by Application (2022-2027)
    Table 45. Global Therapeutic Peptide Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 46. United States Therapeutic Peptide Sales (K Units) of Key Companies (2016-2021)
    Table 47. United States Therapeutic Peptide Sales Share by Company (2016-2021)
    Table 48. United States Therapeutic Peptide Revenue (US$ Million) by Company (2016-2021)
    Table 49. United States Therapeutic Peptide Revenue Share by Company (2016-2021)
    Table 50. United States Therapeutic Peptide Sales (K Units) by Type (2016-2021)
    Table 51. United States Therapeutic Peptide Sales Share by Type (2016-2021)
    Table 52. United States Therapeutic Peptide Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 53. United States Therapeutic Peptide Price (US$/Unit) by Type (2016-2021)
    Table 54. United States Therapeutic Peptide Sales (K Units) by Type (2022-2027)
    Table 55. United States Therapeutic Peptide Sales Share by Type (2022-2027)
    Table 56. United States Therapeutic Peptide Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 57. United States Therapeutic Peptide Revenue Share by Type (2022-2027)
    Table 58. United States Therapeutic Peptide Price (US$/Unit) by Type (2022-2027)
    Table 59. United States Therapeutic Peptide Sales (K Units) by Application (2016-2021)
    Table 60. United States Therapeutic Peptide Sales Share by Application (2016-2021)
    Table 61. United States Therapeutic Peptide Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 62. United States Therapeutic Peptide Price (US$/Unit) by Application (2016-2021)
    Table 63. United States Therapeutic Peptide Sales (K Units) by Application (2022-2027)
    Table 64. United States Therapeutic Peptide Sales Share by Application (2022-2027)
    Table 65. United States Therapeutic Peptide Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 66. United States Therapeutic Peptide Revenue Share by Application (2022-2027)
    Table 67. United States Therapeutic Peptide Price (US$/Unit) by Application (2022-2027)
    Table 68. North America Therapeutic Peptide Sales by Country (2016-2021) & (K Units)
    Table 69. North America Therapeutic Peptide Sales Market Share by Country (2016-2021)
    Table 70. North America Therapeutic Peptide Revenue by Country (2016-2021) & (US$ Million)
    Table 71. North America Therapeutic Peptide Revenue Market Share by Country (2016-2021)
    Table 72. Asia Pacific Therapeutic Peptide Sales by Region (2016-2021) & (K Units)
    Table 73. Asia Pacific Therapeutic Peptide Sales Market Share by Region (2016-2021)
    Table 74. Asia Pacific Therapeutic Peptide Revenue by Region (2016-2021) & (US$ Million)
    Table 75. Asia Pacific Therapeutic Peptide Revenue Market Share by Region (2016-2021)
    Table 76. Europe Therapeutic Peptide Sales by Country (2016-2021) & (K Units)
    Table 77. Europe Therapeutic Peptide Sales Market Share by Country (2016-2021)
    Table 78. Europe Therapeutic Peptide Revenue by Country (2016-2021) & (US$ Million)
    Table 79. Europe Therapeutic Peptide Revenue Market Share by Country (2016-2021)
    Table 80. Latin America Therapeutic Peptide Sales by Country (2016-2021) & (K Units)
    Table 81. Latin America Therapeutic Peptide Sales Market Share by Country (2016-2021)
    Table 82. Latin Americaa Therapeutic Peptide Revenue by Country (2016-2021) & (US$ Million)
    Table 83. Latin America Therapeutic Peptide Revenue Market Share by Country (2016-2021)
    Table 84. Middle East and Africa Therapeutic Peptide Sales by Country (2016-2021) & (K Units)
    Table 85. Middle East and Africa Therapeutic Peptide Sales Market Share by Country (2016-2021)
    Table 86. Middle East and Africa Therapeutic Peptide Revenue by Country (2016-2021) & (US$ Million)
    Table 87. Middle East and Africa Therapeutic Peptide Revenue Market Share by Country (2016-2021)
    Table 88. AbbVie Corporation Information
    Table 89. AbbVie Description and Business Overview
    Table 90. AbbVie Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 91. AbbVie Therapeutic Peptide Product
    Table 92. AbbVie Recent Development
    Table 93. AstraZeneca Corporation Information
    Table 94. AstraZeneca Description and Business Overview
    Table 95. AstraZeneca Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 96. AstraZeneca Product
    Table 97. AstraZeneca Recent Development
    Table 98. Ipsen Corporation Information
    Table 99. Ipsen Description and Business Overview
    Table 100. Ipsen Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 101. Ipsen Product
    Table 102. Ipsen Recent Development
    Table 103. Eli Lilly Corporation Information
    Table 104. Eli Lilly Description and Business Overview
    Table 105. Eli Lilly Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 106. Eli Lilly Product
    Table 107. Eli Lilly Recent Development
    Table 108. Merck Corporation Information
    Table 109. Merck Description and Business Overview
    Table 110. Merck Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 111. Merck Product
    Table 112. Merck Recent Development
    Table 113. Novo Nordisk Corporation Information
    Table 114. Novo Nordisk Description and Business Overview
    Table 115. Novo Nordisk Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 116. Novo Nordisk Product
    Table 117. Novo Nordisk Recent Development
    Table 118. Novartis Corporation Information
    Table 119. Novartis Description and Business Overview
    Table 120. Novartis Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 121. Novartis Product
    Table 122. Novartis Recent Development
    Table 123. Johnson and Johnson Corporation Information
    Table 124. Johnson and Johnson Description and Business Overview
    Table 125. Johnson and Johnson Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 126. Johnson and Johnson Product
    Table 127. Johnson and Johnson Recent Development
    Table 128. Sanofi Corporation Information
    Table 129. Sanofi Description and Business Overview
    Table 130. Sanofi Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 131. Sanofi Product
    Table 132. Sanofi Recent Development
    Table 133. Teva Corporation Information
    Table 134. Teva Description and Business Overview
    Table 135. Teva Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 136. Teva Product
    Table 137. Teva Recent Development
    Table 138. Takeda Corporation Information
    Table 139. Takeda Description and Business Overview
    Table 140. Takeda Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 141. Takeda Product
    Table 142. Takeda Recent Development
    Table 143. Therapeutic Peptide Market Trends
    Table 144. Therapeutic Peptide Market Drivers
    Table 145. Therapeutic Peptide Market Challenges
    Table 146. Therapeutic Peptide Market Restraints
    Table 147. Therapeutic Peptide Customers List
    Table 148. Therapeutic Peptide Distributors List
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Therapeutic Peptide Product Picture
    Figure 2. Global Therapeutic Peptide Sales Market Share by Type in 2020 & 2027
    Figure 3. Oral Product Picture
    Figure 4. Injection Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Therapeutic Peptide Sales Market Share by Application in 2020 & 2027
    Figure 7. Cancer
    Figure 8. Metabolic Disorders
    Figure 9. Central Nervous System
    Figure 10. Other
    Figure 11. Therapeutic Peptide Report Years Considered
    Figure 12. Global Therapeutic Peptide Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Therapeutic Peptide Market Size 2016-2027 (US$ Million)
    Figure 14. Global Therapeutic Peptide Sales 2016-2027 (K Units)
    Figure 15. Global Therapeutic Peptide Market Size Market Share by Region: 2021 Versus 2027
    Figure 16. Global Therapeutic Peptide Sales Market Share by Region (2016-2021)
    Figure 17. Global Therapeutic Peptide Sales Market Share by Region in 2020
    Figure 18. Global Therapeutic Peptide Revenue Market Share by Region (2016-2021)
    Figure 19. Global Therapeutic Peptide Revenue Market Share by Region in 2020
    Figure 20. Global Therapeutic Peptide Sales Share by Manufacturer in 2020
    Figure 21. The Top 10 and 5 Players Market Share by Therapeutic Peptide Revenue in 2020
    Figure 22. Therapeutic Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 23. Global Therapeutic Peptide Sales Market Share by Type (2016-2021)
    Figure 24. Global Therapeutic Peptide Sales Market Share by Type in 2020
    Figure 25. Global Therapeutic Peptide Revenue Market Share by Type (2016-2021)
    Figure 26. Global Therapeutic Peptide Revenue Market Share by Type in 2020
    Figure 27. Global Therapeutic Peptide Sales Market Share by Application (2016-2021)
    Figure 28. Global Therapeutic Peptide Sales Market Share by Application in 2020
    Figure 29. Global Therapeutic Peptide Revenue Market Share by Application (2016-2021)
    Figure 30. Global Therapeutic Peptide Revenue Market Share by Application in 2020
    Figure 31. United States Therapeutic Peptide Sales Growth Rate 2016-2027 (K Units)
    Figure 32. United States Therapeutic Peptide Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 33. United States Therapeutic Peptide Market Share in Global Market 2016-2027
    Figure 34. United States 5 and 10 Largest Therapeutic Peptide Players Market Share by Revenue in Therapeutic Peptide in 2020
    Figure 35. United States Therapeutic Peptide Revenue Share by Type (2016-2021)
    Figure 36. United States Therapeutic Peptide Revenue Growth Rate by Type in 2016 & 2020
    Figure 37. United States Therapeutic Peptide Revenue Share by Application (2016-2021)
    Figure 38. United States Therapeutic Peptide Revenue Growth Rate by Application in 2016 & 2020
    Figure 39. North America Therapeutic Peptide Sales Growth Rate 2016-2021 (K Units)
    Figure 40. North America Therapeutic Peptide Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 41. North America Therapeutic Peptide Sales Market Share by Country in 2020
    Figure 42. North America Therapeutic Peptide Revenue Market Share by Country in 2020
    Figure 43. United States Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 44. United States Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Canada Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 46. Canada Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 47. Europe Therapeutic Peptide Sales Growth Rate 2016-2021 (K Units)
    Figure 48. Europe Therapeutic Peptide Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 49. Europe Therapeutic Peptide Sales Market Share by Country in 2020
    Figure 50. Europe Therapeutic Peptide Revenue Market Share by Country in 2020
    Figure 51. Germany Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 52. Germany Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. France Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 54. France Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. U.K. Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 56. U.K. Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Italy Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 58. Italy Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Russia Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 60. Russia Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 61. Asia Pacific Therapeutic Peptide Sales Growth Rate 2016-2021 (K Units)
    Figure 62. Asia Pacific Therapeutic Peptide Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 63. Asia Pacific Therapeutic Peptide Sales Market Share by Region in 2020
    Figure 64. Asia Pacific Therapeutic Peptide Revenue Market Share by Region in 2020
    Figure 65. China Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 66. China Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. Japan Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 68. Japan Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. South Korea Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 70. South Korea Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. India Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 72. India Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Australia Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 74. Australia Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. China Taiwan Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 76. China Taiwan Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Indonesia Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 78. Indonesia Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Thailand Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 80. Thailand Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Malaysia Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 82. Malaysia Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Latin America Therapeutic Peptide Sales Growth Rate 2016-2021 (K Units)
    Figure 84. Latin America Therapeutic Peptide Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 85. Latin America Therapeutic Peptide Sales Market Share by Country in 2020
    Figure 86. Latin America Therapeutic Peptide Revenue Market Share by Country in 2020
    Figure 87. Mexico Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 88. Mexico Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 89. Brazil Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 90. Brazil Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Argentina Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 92. Argentina Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Middle East and Africa Therapeutic Peptide Sales Growth Rate 2016-2021 (K Units)
    Figure 94. Middle East and Africa Therapeutic Peptide Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 95. Middle East and Africa Therapeutic Peptide Sales Market Share by Country in 2020
    Figure 96. Middle East and Africa Therapeutic Peptide Revenue Market Share by Country in 2020
    Figure 97. Turkey Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 98. Turkey Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 99. Saudi Arabia Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 100. Saudi Arabia Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. UAE Therapeutic Peptide Sales Growth Rate (2016-2021) (K Units)
    Figure 102. UAE Therapeutic Peptide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. Therapeutic Peptide Value Chain
    Figure 104. Channels of Distribution
    Figure 105. Distributors Profiles
    Figure 106. Bottom-up and Top-down Approaches for This Report
    Figure 107. Data Triangulation
    Figure 108. Key Executives Interviewed